financetom
Business
financetom
/
Business
/
Electronic gear maker Amphenol Q3 sales beat estimates, driven by IT datacom market growth
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Electronic gear maker Amphenol Q3 sales beat estimates, driven by IT datacom market growth
Oct 22, 2025 5:35 AM

Overview

* Amphenol ( APH ) Q3 sales rise 53% in U.S. dollars yr/yr, beating analyst expectations

* Adjusted EPS for Q3 beats analyst expectations, rising 86% yr/yr

* Company announces 52% increase in quarterly dividend to $0.25 per share

Outlook

* Amphenol expects Q4 2025 sales between $6.0 bln and $6.1 bln, up 39% to 41% YoY

* Adjusted Diluted EPS for Q4 2025 expected between $0.89 and $0.91

* Amphenol ( APH ) projects 2025 sales between $22.66 bln and $22.76 bln

* Company expects 2025 adjusted diluted EPS between $3.26 and $3.28

Result Drivers

* ORGANIC GROWTH - Strong organic growth in all end markets, particularly IT datacom, drove sales increase

* ACQUISITIONS - Contributions from acquisition program, including Rochester Sensors, supported revenue growth

* OPERATING MARGIN - Record operating margin of 27.5% achieved, reflecting excellent profitability

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Sales Beat $6.19 $5.5 bln

bln (15

Analysts

)

Q3 Beat $0.93 $0.79

Adjusted (15

EPS Analysts

)

Q3 EPS $0.97

Q3 Net $1.26

Income bln

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 14 "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the electronic equipment & parts peer group is "buy"

* Wall Street's median 12-month price target for Amphenol Corp ( APH ) is $130.00, about 4.3% above its October 21 closing price of $124.44

* The stock recently traded at 37 times the next 12-month earnings vs. a P/E of 35 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved